News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
XRP May Lead Institutional Inflows as Bitcoin Holdings Reach $130 Billion Amid Market Shifts
Coinotag·2025/07/30 06:15
XRP Shows Potential for Wave 5 Rally Toward $6.85 Amid Rising Wallet Activity and Key Support
Coinotag·2025/07/30 06:15
Bitcoin Season Likely Dominates Crypto Market as Altcoin Season Index Holds at 38
Coinotag·2025/07/30 06:15
Litecoin Reclaims $116 as Traders Watch for Push Toward $130
Cryptonewsland·2025/07/30 05:50
Bitcoin Holds $117K With Eyes on $123K If Triangle Breaks Soon
Cryptonewsland·2025/07/30 05:50
Altcoin Cool-Off Nears End as RSI Levels Drop—Watch These 4 Tokens Poised for a 60%+ Surge
Cryptonewsland·2025/07/30 05:50
SHIB Burn Rate Explodes 17,000% — Over 600M Tokens Sent to Dead Wallets
Cryptonewsland·2025/07/30 05:50
SEC Eyes Ethereum Staking in ETFs After In-Kind Approval
Cryptotale·2025/07/30 05:47
Ripple CTO reveals why the firm is not currently using XRPL DEX for payments
CryptoSlate·2025/07/30 05:45
Flash
12:56
Spot Gold Drops $14 in Short-Term Spot gold has fallen $14 in the short term, declining over 1.00% during the day, currently reported at $4133.10 per ounce. (Jin Shi)
12:52
Splash Beverage Group Inc. has successfully secured a $1 million strategic investment from C/M Capital Partners.This funding will be specifically allocated for the development of its Cannepil project.
12:51
Vivos (OTC market code: RDGL) has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) and will initiate a human clinical feasibility study of its Radiogel® Precision Radionuclide Therapy™.This approval marks a key step forward for the clinical application of this innovative therapy, allowing the company to begin initial safety and feasibility assessments in humans. The Radiogel® technology is designed to enable precise radiation treatment within tumors and is expected to provide a new treatment option for cancer patients. The approved clinical study will collect essential data to lay the foundation for larger-scale clinical trials in the future.
News